Eleven Biotherapeutics Lands $35,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2b5b263c-a105-4c0e-92e0-a2124661f81d&Preview=1
Date
2/17/2010
Company Name
Eleven Biotherapeutics
Mailing Address
790 Memorial Drive Cambridge, MA 02139
Company Description
Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease.
Website
http://www.elevenbio.com
Transaction Type
Venture Equity
Transaction Amount
$35,000,000
Transaction Round
Series A
Proceeds Purposes
The money and brainpower is being channeled into a company that seeks to engineer proteins with ideal properties for treating autoimmune diseases and blood clotting disorders.
M&A Terms
Venture Investor
Third Rock Ventures
Venture Investor
Flagship Ventures
Venture Investor
Undisclosed